Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$29.06 - $38.83 $48,239 - $64,457
-1,660 Closed
0 $0
Q1 2021

Apr 05, 2021

SELL
$39.04 - $64.6 $54,890 - $90,827
-1,406 Reduced 45.86%
1,660 $72,000
Q4 2020

Jan 20, 2021

BUY
$42.46 - $56.58 $65,048 - $86,680
1,532 Added 99.87%
3,066 $142,000
Q3 2020

Oct 19, 2020

BUY
$37.44 - $64.63 $57,432 - $99,142
1,534 New
1,534 $67,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.53M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.